A phase II trial of regorafenib for advanced urothelial cancer (aUC) following prior chemotherapy

被引：1
|
作者：
Naik, Gurudatta
Vaishampayan, Ulka N.
Nabell, Lisle
De Shazo, Mollie R.
Nandagopal, Lakshminarayanan
Grivas, Petros
Morgan, Charity
Hardwick, Pamela
Sonpavde, Guru
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
498
引用
收藏
页数：2
相关论文
共 50 条
  • [41] WUTSUP-01: Phase II trial of neoadjuvant toripalimab and chemotherapy in locally advanced upper tract urothelial carcinoma
    Liao, X.
    Zhang, P.
    Liu, J.
    Zhang, S.
    Wei, Q.
    Bao, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1562 - S1562
  • [42] Regorafenib in Patients with Antiangiogenic-Naive and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial
    Riechelmann, Rachel P.
    Leite, Luiz S.
    Bariani, Giovanni M.
    Glasberg, Joao
    Rivelli, Thomas G.
    da Fonseca, Leonardo Gomes
    Nebuloni, Daniela R.
    Braghiroli, Maria, I
    Queiroz, Marcelo A.
    Isejima, Alice M.
    Kappeler, Christian
    Kikuchi, Luciana
    Hoff, Paulo M.
    ONCOLOGIST, 2019, 24 (09): : 1180 - 1187
  • [43] A Phase 1 Trial of Regorafenib in Advanced Myeloid Malignancies
    How, Chi-Joan
    Ren, Siyang
    Story, Jennifer Lombardi
    Bergeron, Meghan
    Foster, Julia E.
    Amrein, Philip C.
    Brunner, Andrew M.
    Fathi, Amir T.
    Hock, Hanno R.
    Moran, Jenna A.
    Narayan, Rupa
    Neuberg, Donna S.
    Ramos, Aura Y.
    Som, Tina T.
    Vartanian, Megan
    Chen, Yi-Bin
    Hobbs, Gabriela S.
    BLOOD, 2020, 136
  • [44] A phase II trial of regorafenib as a single agent in patients with advanced and metastatic biliary tract carcinoma and first-line chemotherapy failure
    Patel, Anuj Kishor
    Stoller, Ronald G.
    Rhee, John C.
    Lembersky, Barry C.
    Ohr, James
    Lee, James J.
    Bahary, Nathan
    Chu, Edward
    Sun, Weijing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [45] Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
    Rose, Tracy L.
    Chism, David D.
    Alva, Ajjai S.
    Deal, Allison M.
    Maygarden, Susan J.
    Whang, Young E.
    Kardos, Jordan
    Drier, Anthony
    Basch, Ethan
    Godley, Paul A.
    Dunn, Mary W.
    Kim, William Y.
    Milowsky, Matthew I.
    BRITISH JOURNAL OF CANCER, 2018, 119 (07) : 801 - 807
  • [46] Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
    Tracy L. Rose
    David D. Chism
    Ajjai S. Alva
    Allison M. Deal
    Susan J. Maygarden
    Young E. Whang
    Jordan Kardos
    Anthony Drier
    Ethan Basch
    Paul A. Godley
    Mary W. Dunn
    William Y. Kim
    Matthew I. Milowsky
    British Journal of Cancer, 2018, 119 : 801 - 807
  • [47] Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial
    Witte, RS
    Manola, J
    Burch, PA
    Kuzel, T
    Weinshel, EL
    Loehrer, PJ
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (02) : 191 - 195
  • [48] Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial
    Robert S. Witte
    Judith Manola
    Patrick A. Burch
    Timothy Kuzel
    Eric L. Weinshel
    Patrick J. Loehrer
    Investigational New Drugs, 1998, 16 : 191 - 195
  • [49] EXPERIMENTAL STUDIES AND PHASE-II TRIAL OF BISANTRENE IN ADVANCED UROTHELIAL MALIGNANCIES
    SCHER, HI
    AHMED, T
    YAGODA, A
    KYRIAZIS, AP
    WATSON, RC
    CANCER INVESTIGATION, 1985, 3 (02) : 123 - 127
  • [50] SOGUG-Vexillum: Phase II non-randomized clinical trial of nivolumab/ipilimumab maintenance following first-line chemotherapy in unresectable locally advanced or metastatic urothelial cancer
    de Velasco, Guillermo
    Carbonero, Iciar Garcia
    Anido, Urbano
    Virizuela, Juan Antonio
    Alvarez-Fernandez, Carlos
    Alvarez-Marque, Francisco Jose
    de la Pena, Marina Justo
    Lozano, Rebeca
    Gajate, Pablo
    Reig, Oscar
    Iranzo, Aina
    Pujol, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345